Cardiovascular Systems (CSI; St. Paul, Minnesota) is gaining even more headway with its Diamondback 360° System as the device is set to be evaluated in its treatment of coronary arteries. The company ...
Cardiovascular Systems, Inc. (CSI) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, ...
“CSI’s new 60cm, 4 French devices provide physicians with broader treatment options for challenging lesions in the lower leg,” said David L. Martin, CSI president and chief executive officer. “If left ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Investor Relations, 651-259-2800orSarah Wozniak, 651-259-1636orMatt Sullivan, 612-455-1709orDave Folkens, 612-455-1741 Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company ...
Compliance 360 deg results presented by Dr. Raymond Dattilo show superior outcomes at six months for peripheral arterial disease patients treated with CSI's device. St. Paul, MN & San Francisco, CA ...
Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery ...
Cardiovascular Systems, Inc. Announces FDA Approval of the Coronary ViperWire Advance® With Flex Tip
U.S. Approval of the First and Only Nitinol Atherectomy Guide Wire Expands Company’s Portfolio of Products Targeting Complex Coronary Disease ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, ...
Cardiovascular Systems Inc. (CSI), based in New Brighton, Minnesota, has raised $5 million from the sale of debt, according to documents filed with the Securities and Exchange Commission. The company, ...
CSI has begun a controlled commercial launch of its Diamondback 360 Coronary OAS. Said Martin, “Our initial coronary rollout will be controlled. With a dedicated team of coronary sales specialists, we ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Investor Relations, 651-259-2800orSarah Wozniak, 651-259-1636orMatt Sullivan, 612-455-1709orDave Folkens, 612-455-1741 Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results